DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
03 05 2021
Historique:
received: 26 06 2020
accepted: 25 02 2021
pubmed: 3 3 2021
medline: 6 10 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

A primordial gut-epithelial innate defense response is the release of hydrogen peroxide by dual NADPH oxidase (DUOX). In inflammatory bowel disease (IBD), a condition characterized by an imbalanced gut microbiota-immune homeostasis, DUOX2 isoenzyme is the highest induced gene. Performing multiomic analyses using 2872 human participants of a wellness program, we detected a substantial burden of rare protein-altering DUOX2 gene variants of unknown physiologic significance. We identified a significant association between these rare loss-of-function variants and increased plasma levels of interleukin-17C, which is induced also in mucosal biopsies of patients with IBD. DUOX2-deficient mice replicated increased IL-17C induction in the intestine, with outlier high Il17c expression linked to the mucosal expansion of specific Proteobacteria pathobionts. Integrated microbiota/host gene expression analyses in patients with IBD corroborated IL-17C as a marker for epithelial activation by gram-negative bacteria. Finally, the impact of DUOX2 variants on IL-17C induction provided a rationale for variant stratification in case control studies that substantiated DUOX2 as an IBD risk gene. Thus, our study identifies an association of deleterious DUOX2 variants with a preclinical hallmark of disturbed microbiota-immune homeostasis that appears to precede the manifestation of IBD.

Identifiants

pubmed: 33651715
pii: 141676
doi: 10.1172/JCI141676
pmc: PMC8087203
doi:
pii:

Substances chimiques

IL17C protein, human 0
Il17c protein, mouse 0
Interleukin-17 0
Dual Oxidases EC 1.11.1.-
DUOX2 protein, human EC 1.6.3.1
Duox2 protein, mouse EC 1.6.3.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : BLRD VA
ID : I01 BX001245
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA210967
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK124779
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034933
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK117565
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES017885
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK054221
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Gastroenterology. 2015 Dec;149(7):1849-59
pubmed: 26261005
Mol Endocrinol. 2007 Jun;21(6):1408-21
pubmed: 17374849
Bioinformatics. 2018 Apr 15;34(8):1411-1413
pubmed: 29028892
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
PLoS One. 2017 Oct 5;12(10):e0186142
pubmed: 28982144
Am J Hum Genet. 2016 Jan 7;98(1):165-84
pubmed: 26748518
J Biol Chem. 2006 Jul 7;281(27):18269-72
pubmed: 16651268
Nat Immunol. 2011 Oct 12;12(12):1151-8
pubmed: 21993849
Gastroenterology. 2016 Oct;151(4):698-709
pubmed: 27373512
Gastroenterology. 2013 Nov;145(5):1045-54
pubmed: 23860501
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Genet Epidemiol. 2015 May;39(4):276-93
pubmed: 25810074
Cell. 2015 Oct 8;163(2):367-80
pubmed: 26411289
Am J Hum Genet. 2016 Jan 7;98(1):127-48
pubmed: 26748516
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
PLoS Genet. 2018 May 24;14(5):e1007329
pubmed: 29795570
Infect Immun. 2017 Sep 20;85(10):
pubmed: 28739826
EMBO Rep. 2013 Apr;14(4):319-27
pubmed: 23478337
Sci Rep. 2018 Jul 5;8(1):10158
pubmed: 29977049
Science. 2005 Nov 4;310(5749):847-50
pubmed: 16272120
Nucleic Acids Res. 2017 Jul 3;45(W1):W130-W137
pubmed: 28472511
BMC Genomics. 2012;13 Suppl 8:S20
pubmed: 23282288
J Interferon Cytokine Res. 2012 Dec;32(12):583-91
pubmed: 22994872
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8141-E8150
pubmed: 27911839
J Clin Invest. 2014 Aug;124(8):3617-33
pubmed: 25003194
Nucleic Acids Res. 2011 Aug;39(15):e102
pubmed: 21646338
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4659-65
pubmed: 20615996
Nat Commun. 2015 Sep 22;6:8292
pubmed: 26392213
PLoS Genet. 2009 Feb;5(2):e1000384
pubmed: 19214210
Cell. 1992 Mar 6;68(5):869-77
pubmed: 1547488
Am J Respir Cell Mol Biol. 2014 Jan;50(1):30-9
pubmed: 23944933
Cell. 2015 Oct 8;163(2):381-93
pubmed: 26411290
Microbiol Immunol. 1995;39(8):555-62
pubmed: 7494493
Front Immunol. 2020 Feb 26;11:341
pubmed: 32174926
Best Pract Res Clin Gastroenterol. 2014 Jun;28(3):373-86
pubmed: 24913378
PLoS One. 2015 Nov 04;10(11):e0141710
pubmed: 26536229
Infect Immun. 2018 Apr 23;86(5):
pubmed: 29507083
Am J Hum Genet. 2007 Apr;80(4):727-39
pubmed: 17357078
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Mucosal Immunol. 2015 Jul;8(4):943-58
pubmed: 25492478
Infect Immun. 2009 Nov;77(11):4983-9
pubmed: 19687201
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Mol Endocrinol. 2012 Mar;26(3):481-92
pubmed: 22301785
Eur J Hum Genet. 2017 Apr;25(4):477-484
pubmed: 28145424
Nat Biotechnol. 2013 Sep;31(9):814-21
pubmed: 23975157
Nature. 2015 Jan 8;517(7533):205-8
pubmed: 25337874
Cell Mol Gastroenterol Hepatol. 2015 Sep 1;1(5):489-502
pubmed: 26301257
Res Synth Methods. 2017 Dec;8(4):537-553
pubmed: 28801932
Nat Immunol. 2011 Oct 12;12(12):1159-66
pubmed: 21993848
Gastroenterology. 2017 Aug;153(2):609-611.e3
pubmed: 28683258
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Cell Host Microbe. 2016 May 11;19(5):651-63
pubmed: 27173933
Gut. 2012 Aug;61(8):1124-31
pubmed: 22115825
Nature. 2015 Mar 5;519(7541):92-6
pubmed: 25731162
United European Gastroenterol J. 2019 Dec;7(10):1426-1430
pubmed: 31839967
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344
Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G467-G475
pubmed: 28751424
Cell. 2009 Oct 30;139(3):485-98
pubmed: 19836068

Auteurs

Helmut Grasberger (H)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Andrew T Magis (AT)

Institute for Systems Biology, Seattle, Washington, USA.
Arivale Inc., Seattle, Washington, USA.

Elisa Sheng (E)

Arivale Inc., Seattle, Washington, USA.

Matthew P Conomos (MP)

Arivale Inc., Seattle, Washington, USA.
Department of Biostatistics, University of Washington, Seattle, Washington, USA.

Min Zhang (M)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Lea S Garzotto (LS)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Guoqing Hou (G)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Shrinivas Bishu (S)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Hiroko Nagao-Kitamoto (H)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Mohamad El-Zaatari (M)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Sho Kitamoto (S)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Nobuhiko Kamada (N)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Ryan W Stidham (RW)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Yasutada Akiba (Y)

West Los Angeles VA Medical Center and Departments of Medicine and Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Jonathan Kaunitz (J)

West Los Angeles VA Medical Center and Departments of Medicine and Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Yael Haberman (Y)

Cincinnati Children's Hospital Medical Center, and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Subra Kugathasan (S)

Departments of Pediatrics and Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.

Lee A Denson (LA)

Cincinnati Children's Hospital Medical Center, and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Gilbert S Omenn (GS)

Departments of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics, and School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.

John Y Kao (JY)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH